BIT
BIIB icon

BlackRock Institutional Trust’s Biogen BIIB Stock Holding History

BlackRock Institutional Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,500
Closed -$1.07M – 3943
2014
Q1 		$1.07M Buy
+3,500
New +$1.11M ﹤0.01% 3397

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Institutional Trust's BIIB Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Biogen (BIIB) stake by 4% in Q4 2016, buying an estimated $69.9M and bringing the position to 6,102,240 shares worth $1.73B. The position accounts for 0.26% of the portfolio, ranked #71.

BlackRock Institutional Trust first reported a position in BIIB in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.63B in Q1 2015. 1,025 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • BlackRock Institutional Trust held 6,102,240 shares of Biogen worth $1.73B as of Q4 2016.
  • BlackRock Institutional Trust bought 235,872 Biogen shares in Q4 2016, an estimated $69.9M.
  • Biogen made up 0.26% of BlackRock Institutional Trust's portfolio in Q4 2016, its #71 holding.
  • BlackRock Institutional Trust first reported a position in Biogen in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Biogen position peaked at $2.63B in Q1 2015.
  • 1,025 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.